Advertisement

Metaplastic Carcinoma of the Breast: MRI Features with Clinical and Histopathologic Correlation

Published:September 19, 2022DOI:https://doi.org/10.1016/j.acra.2022.08.026

      Rationale and Objectives

      Metaplastic carcinoma of the breast (MCB) is a rare type of breast carcinoma, and there are only limited data about the MRI findings of MCB. This article aimed to review the MRI features of MCB and correlate the MRI findings with clinical and histopathologic characteristics.

      Materials and Methods

      A total of 23 patients were enrolled from a signal institution. The clinical data, histological diagnosis and MRI findings were retrospectively reviewed.

      Results

      The average age of the 23 patients was 51.6 years. Twenty-one (91.3%) patients presented with a palpable mass. Squamous cell carcinoma was the most common subtype (10/23, 43.5%). Axillary lymph node metastasis was detected in 4 (17.4%) patients. The immunohistochemical profile showed the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor-2 (Her-2) expression were negative in 87.0%, 95.7%, and 91.3% of the patients respectively. On MRI, most cases exhibited an irregular mass (18/23, 78.3%) with high signal intensity on T2-weighted images (22/23,95.7%), non-circumscribed margin (19/23, 82.6%), heterogeneous enhancement (13/23, 56.5%), Type III (12/23, 52.2%) time intensity curve, and diffusion restriction (20/23, 87.0%) on diffusion weighted images (DWI).

      Conclusion

      MCB most commonly demonstrated definitely malignant MRI features, which may reflect the histopathologic characteristic of this rare and aggressive breast carcinoma.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yang WT
        • Hennessy B
        • Broglio K
        • et al.
        Imaging differences in metaplastic and invasive ductal carcinomas of the breast.
        AJR Am J Roentgenol. 2007; 189: 1288-1293
        • Leddy R
        • Irshad A
        • Rumboldt T
        • et al.
        Review of metaplastic carcinoma of the breast: imaging findings and pathologic features.
        J Clin Imaging Sci. 2012; 2: 21
        • Bian T
        • Lin Q
        • Wu Z
        • et al.
        Metaplastic carcinoma of the breast: Imaging and pathological features.
        Oncol Lett. 2016; 12: 3975-3980
        • Choi BB
        • Shu KS.
        Metaplastic carcinoma of the breast: multimodality imaging and histopathologic assessment.
        Acta Radiol. 2012; 53: 5-11
        • Huvos AG
        • Lucas Jr, JC
        • Foote Jr., FW
        Metaplastic breast carcinoma: Rare form of mammary cancer.
        NY State J Med. 1973; 73: 1078-1082
        • Fritz A
        • Percy C
        • Jack A
        • et al.
        International classification of diseases of oncology.
        3rd edn. World Health Organization, Geneva2000
        • WHO Classifcation of Tumors Editorial Board
        WHO classification of tumors, 5th edition – Breast tumors.
        International Agency for Research on Cancer, Lyon2019
        • Luini A
        • Aguilar M
        • Gatti G
        • et al.
        Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature.
        Breast Cancer Res Treat. 2007; 101: 349-353
        • Pezzi CM
        • Patel-Parekh L
        • Cole K
        • et al.
        Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base.
        Ann Surg Oncol. 2007; 14: 166-173
        • El Zein D
        • Hughes M
        • Kumar S
        • et al.
        Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer: a study from a single institution and review of literature.
        Clin Breast Cancer. 2017; 17: 382-391
        • Langlands F
        • Cornford E
        • Rakha E
        • et al.
        Imaging overview of metaplastic carcinomas of the breast: a large study of 71 cases.
        Br J Radiol. 2016; 8920140644
        • Velasco M
        • Santamaría G
        • Ganau S
        • et al.
        MRI of metaplastic carcinoma of the breast.
        AJR Am J Roentgenol. 2005; 184: 1274-1278
        • Donato H
        • Candelaria I
        • Oliveira P
        • et al.
        Imaging findings of metaplastic carcinoma of the breast with pathologic correlation.
        Journal of the Belgian Society of Radilolgy. 2018; 102: 1-8
        • Rakha EA
        • Tan PH
        • Varga Z
        • et al.
        Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study.
        Brit J Cancer. 2014; 112: 283-289
        • Zhang Lv F
        • Yang Y
        • et al.
        Clinicopathological features and prognosis of metaplastic breast carcinoma: experience of a major chinese cancer center.
        PLoS One. 2015; 26 (10)e0131409
        • Shin HJ
        • Kim HH
        • Kim SM
        • et al.
        Imaging features of metaplastic carcinoma with chondroid differentiation of the breast.
        AJR Am J Roentgenol. 2007; 188 (Mar): 691-696
        • Greenberg D
        • McIntyre H
        • Bierre T.
        Metaplastic breast cancer.
        Australas Radiol. 2004; 48: 243-247
        • Barnes PJ
        • Boutilier R
        • Chiasson D
        • et al.
        Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expression.
        Breast Cancer Res Treat. 2005; 91: 173-178
        • Jia Y
        • He CJ
        • Liu LN
        • et al.
        A retrospective study of the imaging and pathological features of metaplastic breast carcinoma and review of the literature.
        Med Sci Monit. 2019; 25: 248-258
        • Thennavan A
        • Beca F
        • Xia Y
        Molecular analysis of TCGA breast cancer histologic types.
        Cell Genom. 2021; 1100067
      1. Jha A, Agrawal V, Tanver N, et al. Metaplastic breast carcinoma presenting as benign breast lump. J Cancer Res Ther, 2017;13(3):593-596.

        • Santamaría G
        • Velasco M
        • Bargalló X
        • et al.
        Radiologic and pathologic findings in breast tumors with high signal intensity on T2-weighted MR images.
        Radiographics. 2010; 30: 533-548
        • Yoo JL
        • Woo OH
        • Kim YK
        • et al.
        Can MR Imaging contribute in characterizing well-circum- scribed breast carcinomas?.
        Radiographics. 2010; 30: 1689-1702
        • Patterson SK
        • Tworek JA
        • Roubidoux MA
        • et al.
        Metaplastic carcinoma of the breast: Mammographic appearance with pathologic correlation.
        Am J Roentgenol. 1997; 169: 709-712
        • Gladys G
        • Victor AI
        • John K
        • et al.
        Diffusion-weighted magnetic resonance imaging of breast lesions : first experiences at 3T.
        Comput Assist Tomogr. 2009; 33: 63-69